JEFFERIES praises Dermapharm for ‘Buy’

NEW YORK (dpa-AFX Analyser) – Jefferies’ analysis house has made the purchase for Dermapharm with a price of 49 euros for “Buy” prices. Dies Schrieb Analyst Fabian Piasta is working at the Donnerstag with the Finance Chief and the Manager for Partner and Business Operations (CCO)./ag/gl

Veröffentlichung der Original-Studie: 05.09.2024 / 13:35 / ET First Weitergabe of Original-Studie: 05.09.2024 / 19:00 / ET

Note: Information about Offenlegungspflicht bei Interessenkonflikten im Sinne von § 85 Abs. 1 WpHG, art. 20 VO (EU) 596/2014 for the generated analyst house can be found at http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.

The Dermapharm Holding Aktie is a company that sells a product with a plus of +0.15 % and a course of 32.70EUR traded on Tradegate (06. September 2024, 11:38 Uhr).